2019 MDMA Medical Technology Executive Forum Agenda


*Speakers will be added as confirmed

Click Here for a PDF of the Agenda

Friday, September 13, 2019

7:15am - 7:55am
Registration and Breakfast

7:55am - 8:00am
Welcoming Remarks

  • Mark Leahey, President & CEO, MDMA

8:00am - 8:20am
Trends in Healthcare Investments & Exits

Learn about the latest funding trends and active investors in the medical technology sector. Get a deep dive into venture M&A activity, with an acquirer analysis and predictions on what to expect in the coming years. 

  • Jonathan Norris, Managing Director, Silicon Valley Bank (SVB)

8:20am - 9:00am

Best Strategies for Raising Capital

Hear from leading angel, venture capital and strategic investors on the most-effective strategies to raise funding. This session will explore a variety of avenues as well as new areas of interest to the investment community.

  • Ajay Khatri, Director, Venture Investments, Johnson & Johnson Innovation
  • Allan May, Chairman & Founder, Life Science Angels
  • Casey McGlynn, Partner, WSGR (moderator)
  • Ned Scheetz, General Partner & Founder, Aphelion Capital
  • Benjamin Tsai, Partner, Invus Opportunities Fund

9:00am - 9:55am
CDRH Update

FDA continues to examine the regulatory pathways and provide new reform proposals, and hear from the CDRH Director (via videoconference) on what steps they are taking and to have your questions answered on the latest priorities for the agency.  Learn firsthand how the agency envisions the latest proposals and agency realignments to spur improvements for patient care, and how stakeholders can continue working together to improve the regulatory pathways. 

  • Jeffery Shuren, MD, Director, CDRH, FDA

9:55am - 10:10am

Networking Break

10:10am - 11:00am

Lessons Learned from Industry Leaders

Legendary med tech innovators will discuss where they see the industry moving in the 21st Century, and how today’s entrepreneurs can overcome the headwinds we all confront and address the pressing needs facing patient care.

  • Thomas Fogarty, MD, Founder & Director, Fogarty Institute for Innovation
  • Mir Imran, Chairman & Founder, InCube Labs

11:00am - 11:30am

Diversity in Healthtech Innovation

As the innovation ecosystem continues to evolve and become more diverse, hear unique perspectives on how teams and companies can harness their collective assets.

  • Mike Regan, Chief Innovation Officer, Fogarty Institute for Innovation
  • Maria Sainz, President & CEO, AEGEA Medical
  • Paul Yock, Founding Co-Chair, Stanford Biodesign

11:30am - 12:15pm
Reimbursement Reforms - Accelerating Patient Access

Challenges with coding, coverage and reimbursement unfortunately continue to keep innovators up at night, and increasingly are becoming the largest roadblock to growth.  Executives in the payor community and experts on how to navigate the processes will share their best-practices on how you can ultimately overcome these challenges.

  • Michael Beebe, Vice President, ADVI (moderator)
  • Adi Renbaum, President, ANR Consulting, LLC
  • Jyme Schafer, MD, MPH, Contractor Medical Director, Clinical Affairs, Novitas Solutions

12:15pm - 1:10pm

Buffet Lunch


1:10pm - 1:55pm

International: Timelines for the Transition to MDR

On the heels of the ongoing frustrations with “Brexit,” the European Union’s updates to the medical devices regulations (MDR) are compounding the difficulties.  Learn from some of the world’s top international experts on what to expect with the shrinking number of notified bodies, and what your team needs to be working on right now to successfully launch in Europe.

  • Ed Rozynski, Senior International Advisor, MDMA (moderator)
  • Royth von Hahn, Senior Vice President, Global Head of Medical & Health Services, TUV SUD Product Service Division

1:55pm - 2:10pm

Networking Break

2:10pm - 2:55pm

Compliance Developments: What You & Your Team Need to Know
In this session, experienced compliance officers and attorneys will examine real-life scenarios and best practices for minimizing risk and improving ethics in your organization.

  • Carolyn Bruguera, VP & General Counsel, MDMA
  • Amy Hargreaves, Associate, Latham & Watkins
  • Alaleh Nouri, SVP, GC and Chief Compliance Officer, PROCEPT BioRobotics
  • John Richter, Partner, King & Spalding

2:55pm - 4:15pm
Key Issues that Can Impact Your Companies Success
More than ever, medical technology executives need to quickly pivot and address the myriad of challenges their teams will face. This rapid-fire panel of experts will share the "must know" strategies on how to confront them all, from protecting your IP, cybersecurity and more.

      2:55pm - 3:15pm
Recent Patents/IP Developments

  • Arpita Bhattacharyya, PhD, Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

      3:15pm - 3:35pm

      Cybersecurity & Patient Safety

  • Paul Otto, Partner, Hogan Lovells

      3:35pm - 3:55pm

      Preventing the Preventable: Stress Testing Insurance Vulnerabilities - What Medical Device Executives Need to Know

  • Matt Cohn, Sr. Vice President, Alliant

      3:55pm - 4:15pm

      Evaluating Incentives & Resources for Your Site Selection

  • Austin Barrett, Partner, T3 Advisors



Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.